ArticleJournal of immunology (Baltimore, Md. : 1950)2019
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.
Philipp Haselmayer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
90 papers cite itlatest 60 shown
this paperpooled ittrialcites it